Remove 2011 Remove Industry Remove Pharmaceuticals Remove Technology
article thumbnail

Performance Measurement

Strategy Driven

Medium-term value drivers look forward to indicate whether a company can maintain and improve its revenue growth and ROIC over the next one to five years (or longer for companies, such as pharmaceutical manufacturers, that have long product cycles). As with the other measures, what is important varies by industry. Copyright (c) 2011.

ROIC 62
article thumbnail

Lipitor and iPhone 4s: Setting the Stage for Industry Disruption

Harvard Business Review

The two biggest product stories of 2011 were arguably Lipitor and the iPhone 4S. The iPhone 4S's story seems to be about a new beginning: the highly anticipated launch of the latest version of a blockbuster consumer-technology product. And both teach lessons that apply across many industries. Both Pfizer and.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Technology Progresses When Business, Government, and Academia Work Together

Harvard Business Review

By the mid-1980’s, the American semiconductor industry seemed like it was doomed. Although US firms had pioneered and dominated the technology for two decades, they were now getting pummeled by cheaper Japanese imports. The initial breakthrough came in 1987, but the first drug wasn’t approved until 2011.

article thumbnail

The State of Strategy Consulting, 2011

Harvard Business Review

Meanwhile behemoths such as McKinsey and BCG, to maintain their above-industry-average growth rates and keep their global office networks humming, have broadened what they do and moved down the food chain. Marakon , which put value-based management at the core of its strategy concentration, is essentially defunct. Monitor & Co.,

article thumbnail

Why America Is Losing Its Entrepreneurial Edge

Harvard Business Review

The rate of business formation in 2011 was almost half of what it was in 1978, with the rate of dissolution somewhat higher than the past couple decades. Consolidation of the financial sector has led to similar dynamics in other industries. In pharmaceuticals, the largest company, Pfizer, is the result of decades of mergers.

article thumbnail

Big Pharma's Mixed Modes of Growth

Harvard Business Review

They might make a targeted acquisition here or there, form an alliance now and again, or license in some specialized technology, but by and large they made their own drugs, supporting big, fully staffed research labs, which they would then market themselves. Historically, big pharma firms made their own drugs.

article thumbnail

Recommended Resources – An Interview with Paul Leinwand and Cesare Mainardi, authors of The Essential Advantage

Strategy Driven

We’ve established a strong correlation between coherence, as we define it, and superior performance over time in a number of industries. Those companies that focus on building a system of three to six best-in-class, interlocking capabilities that support their way to play achieve a right to win in their industries.